Induced cell death pathway post photodynamic therapy using a metallophthalocyanine photosensitizer in breast cancer cells

Photomed Laser Surg. 2014 Apr;32(4):205-11. doi: 10.1089/pho.2013.3650. Epub 2014 Mar 24.

Abstract

Objective: Zinc phthalocyanine (ZnPcSmix) was used as the photosensitizer (PS) in this study to investigate the cell death patterns as a result of photodynamic therapy (PDT) in a breast cancer cell line (MCF-7) in vitro using a 680 nm diode laser at a fluence of 5 J/cm(2).

Background: PDT is a noninvasive form of cancer therapy, successfully applied for the treatment of various cancer types.

Methods: Flow cytometry using Annexin V-fluorescein isothiocyanate (FITC), a cell death immunosorbent assay (ELISA), and gene expression analysis following ZnPcSmix mediated PDT were performed to determine the induced cell death pathways.

Results: The apoptotic cells abounded after the treatment, nuclear fragmentation was seen as oligonucleosomal degradation and increased expression of the B-cell lymphoma 2 (Bcl-2), DNA fragmentation factor alpha (DFFA1), and caspase 2 (CASP2) genes, indicated that apoptosis is the main induced mode of cell death.

Conclusions: ZnPcSmix mediated PDT led to an apoptotic cell death pathway and the PS used showed its ability to stimulate and initiate programmed cell death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cell Death / physiology*
  • Cells, Cultured
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Isoindoles
  • Organometallic Compounds / therapeutic use*
  • Photochemotherapy / methods*
  • Photosensitizing Agents / therapeutic use*
  • Zinc Compounds

Substances

  • Indoles
  • Isoindoles
  • Organometallic Compounds
  • Photosensitizing Agents
  • Zinc Compounds
  • Zn(II)-phthalocyanine